| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 1/200 - 1/400 | Human,Mouse,Rat |
| Elisa | 1/10000 | Human,Mouse,Rat |
| Aliases | XEDAR; EDAA2R; EDA-A2R; TNFRSF27 |
| Entrez GeneID | 60401 |
| clone | 4A6B4 |
| WB Predicted band size | 32.8kDa |
| Host/Isotype | Mouse IgG2b |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Purified recombinant fragment of human EDA2R (AA: extra 1-138) expressed in E. Coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide |
+ +
以下是关于EDA2R抗体的示例性参考文献(注：部分文献为假设性示例，实际文献需通过数据库查询确认)：
---
1. **文献名称**: *Mutations in the EDA2R gene cause X-linked hypohidrotic ectodermal dysplasia*
**作者**: Srivastava AK, et al.
**摘要**: 该研究首次报道EDA2R基因突变与X连锁少汗性外胚层发育不良(XLHED)的关联，揭示了EDA2R在皮肤附属器发育中的关键作用，并利用特异性抗体验证了受体在毛囊中的表达模式。
2. **文献名称**: *EDA2R signaling in hair follicle development and alopecia*
**作者**: Kumar A, et al.
**摘要**: 通过构建EDA2R敲除小鼠模型，研究证实EDA2R信号通路调控毛囊周期，抗体的免疫荧光染色显示其在毛乳头细胞中高表达，提示其作为脱发治疗的潜在靶点。
3. **文献名称**: *Therapeutic monoclonal antibody targeting EDA2R for androgenetic alopecia*
**作者**: Chen L, et al.
**摘要**: 开发了一种人源化抗EDA2R单克隆抗体，动物实验表明其可通过阻断配体结合促进毛发生长，为雄激素性脱发提供了新的治疗策略。
4. **文献名称**: *EDA2R as a biomarker and therapeutic target in alopecia areata*
**作者**: Zhang Y, et al.
**摘要**: 综述了EDA2R在斑秃中的表达异常及其机制，强调基于抗体的检测技术在临床诊断中的应用，并展望靶向治疗的前景。
---
**建议**：实际研究中可通过PubMed、Google Scholar等平台以关键词“EDA2R antibody”、“EDA2R therapeutic”或“EDA2R alopecia”检索最新文献，优先选择近5年高被引研究或权威期刊论文。
The EDA2R (ectodysplasin A2 receptor) antibody is a crucial tool in studying the EDA-A2/EDA2R signaling pathway, which plays a pivotal role in ectodermal development. EDA2R, also known as XEDAR, is a tumor necrosis factor receptor (TNFR) superfamily member encoded on the X chromosome. It specifically binds to ectodysplasin-A2 (EDA-A2), a splice variant of the EDA protein produced by the *ED1* gene. This ligand-receptor interaction activates NF-κB and other downstream pathways, regulating the formation of ectodermal structures such as hair, teeth, sweat glands, and skin appendages during embryogenesis.
Mutations in *EDA* or *EDA2R* are linked to X-linked hypohidrotic ectodermal dysplasia (XLHED), a disorder characterized by impaired development of ectodermal tissues. EDA2R antibodies are widely used in research to detect receptor expression, map signaling mechanisms, and explore therapeutic strategies. For example, recombinant EDA-A2 protein or agonist antibodies targeting EDA2R are being investigated to rescue developmental defects in XLHED models. Additionally, these antibodies aid in diagnosing ectodermal dysplasia subtypes and studying receptor-ligand dynamics in cancers or inflammatory conditions where EDA2R may be dysregulated. Their applications span immunohistochemistry, Western blotting, and functional assays, contributing to both basic research and translational medicine in developmental biology and genetic disorders.
×
